Healthcare - Biotechnology - NASDAQ - US
$ 4.95
-13.6 %
$ 95.6 M
Market Cap
-4.27
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
37.35%
Net Income
Estimate
27.50%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Nuvectis Pharma, Inc.
NVCT has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart NVCT
EBIT FORECAST
EBIT Forecast Chart NVCT
NET INCOME FORECAST
Net Income Chart NVCT